Donald J Kellerman is VP, Clinical Dev & Med Affairs of Zosano Pharma Corp. Currently has a direct ownership of 56,331 shares of ZSANQ, which is worth approximately $0. The most recent transaction as insider was on Mar 31, 2022, when has been sold 4,006 shares (Common Stock) at a price of $0.21 per share, resulting in proceeds of $841. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.3K
0% 3M change
0% 12M change
Total Value Held $0

DONALD J KELLERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
SELL
Open market or private sale
$841 $0.21 p/Share
4,006 Reduced 6.64%
56,331 Common Stock
Oct 15 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 14.22%
60,337 Common Stock
Jun 04 2021
SELL
Open market or private sale
$1,367 $0.8 p/Share
1,709 Reduced 3.28%
50,337 Common Stock
Mar 30 2021
BUY
Grant, award, or other acquisition
-
32,500 Added 38.44%
52,046 Common Stock
DJK

Donald J Kellerman

VP, Clinical Dev & Med Affairs
Fremont, CA

Track Institutional and Insider Activities on ZSANQ

Follow Zosano Pharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZSANQ shares.

Notify only if

Insider Trading

Get notified when an Zosano Pharma Corp insider buys or sells ZSANQ shares.

Notify only if

News

Receive news related to Zosano Pharma Corp

Track Activities on ZSANQ